Cost-effectiveness analysis of capecitabine versus active monitoring in stable or responding metastatic colorectal cancer after 16 weeks of first-line therapy
Tong Liu, Ruihong Yao, Zhiqiang Tong, Mei Dong, Lu Zhong
:31
:Annals of Medicine
: